Capricor Therapeutics, Inc. (CAPR)
6.69
-0.02
(-0.30%)
USD |
NASDAQ |
Oct 19, 13:21
Capricor Therapeutics Cash from Operations (Annual) : -69.81M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -69.81M |
| December 31, 2024 | -40.00M |
| December 31, 2023 | -25.60M |
| December 31, 2022 | 4.917M |
| December 31, 2021 | -16.81M |
| December 31, 2020 | -10.05M |
| December 31, 2019 | -6.822M |
| December 31, 2018 | -13.86M |
| December 31, 2017 | -14.23M |
| December 31, 2016 | -17.55M |
| December 31, 2015 | -13.79M |
| December 31, 2014 | 2.534M |
| December 31, 2013 | -4.742M |
| Date | Value |
|---|---|
| December 31, 2012 | -2.187M |
| December 31, 2011 | -4.649M |
| December 31, 2010 | -4.318M |
| December 31, 2009 | -5.796M |
| December 31, 2008 | -10.64M |
| December 31, 2007 | -5.373M |
| December 31, 2006 | -0.0556M |
| December 31, 2005 | -0.0178M |
| December 31, 2004 | -0.0155M |
| December 31, 2003 | -0.0208M |
| December 31, 2002 | -0.0143M |
| December 31, 2001 | -0.013M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ARS Pharmaceuticals, Inc. | -170.87M |
| SELLAS Life Sciences Group, Inc. | -28.39M |
| Sionna Therapeutics, Inc. | -66.30M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Cytokinetics, Inc. | -510.01M |